Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.1.18 (
branching enzyme
)
628
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A 30-year-old woman with clinical features and biochemical findings of muscle phosphofructokinase deficiency was found to have a very low level of alpha-1,4-glucan:alpha-1,4-glucan-6-
transglucosylase
(
branching enzyme
,
EC 2.4.1.18
) activity in muscle. In contrast,
branching enzyme
activity in the leukocytes was in the range of control values. After sedimentation of the glycogen from muscle homogenates by centrifugation at 105,000 g,
branching enzyme
activity in muscle of the patient was similar to that of control subjects. This patient illustrates the possibility of falsely diagnosing
branching enzyme
deficiency when muscle glycogen content is elevated. It is likely that such an artefact may also cause a false positive diagnosis of
branching enzyme
deficiency in other metabolic diseases associated with glycogen accumulation.
...
PMID:Apparent absence of glycogen branching enzyme activity in phosphofructokinase deficiency. 183 26
Glycogenosis type IV is caused by a deficiency of
glycogen branching enzyme
(alpha-1,4 glucan 6-
transglucosylase
). Adult polyglucosan body disease (APBD) may represent a neuropathological hallmark of the adult form of this storage disease of the central nervous system. We analysed a case of a 45-year-old unconscious woman who died three days after admission to the hospital. Neuropathological examination revealed massive accumulation of polyglucosan bodies (PBs) in the cortex and white matter of the whole brain. PBs were located in the processes of neurons, astrocytes and microglial cells. The storage material in the cytoplasm of neurons and glial cells was visible as fine granules. Ultrastructurally, PBs consisted of non-membrane-bound deposits of branched and densely packed filaments, measuring about 7-10 nm in diameter, typical of polyglucosan bodies. APBD patients develop upper and lower neuron disease and dementia, probably secondary to the disruption of neuron and astrocyte functions.
...
PMID:Immunohistochemical and ultrastructural changes in the brain in probable adult glycogenosis type IV: adult polyglucosan body disease. 1882 92